The Medi-Globe Group has entered into an innovative research collaboration with the French Institut Hospitalo-Universitaire (IHU) in Strasbourg. The focus of the collaboration is the first software AI in the world for the detection of pancreatic diseases in endoscopic ultrasound examinations. As an industrial partner of the IHU, the Medi-Globe Group is thus further expanding its role as a leader in innovation in minimally invasive diagnostics and therapies.
Medi-Globe Group CEO Martin Lehner said: “Together with the researchers at the IHU we will develop the world's first software for diagnosing pancreatic diseases to market maturity.
Last Monday, the Financial Times announced a deal with OpenAI. FT licenses its world-class journalism…
Millions of people pay for streaming services, paying monthly subscription fees. It is common opinion that you…
Coveware by Veeam will continue to provide cyber extortion incident response services. Coveware will offer forensics and remediation capabilities…
Predictive maintenance is revolutionizing the oil & gas sector, with an innovative and proactive approach to plant management.…
